no_free_lunch Posted July 22, 2018 Share Posted July 22, 2018 Platform is divesting Ayrsta for $4.2B. WIll significantly lower leverage, down to 2.5x EBITDA. Company has announced a buyback of ~23% of market cap. Will convert to an operating company. Some cost savings. https://seekingalpha.com/article/4188775-platform-specialty-products-pah-divest-arysta-lifescience-4_2b-slideshow Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now